Summary
Healthplus.ai has developed a Proof-of-Concept version (TRL level 3) of an Artificial Intelligence (AI) tool to be offered as a Software as a Service (SaaS) solution and able to automatically and very precisely annotate, segment and 3D visualize unique bone and fracture patient cases (goal is >98% accuracy compared to 90-92 with current solutions), within minutes (instead of hours to days), and at a fraction of current cost (€10 vs €1,200). This process will hence also enable automated and expedient determination to do exact measurements of distances, angles, depths, and making a list of required prosthetic materials to perform the bone operation as efficient and effective as possible. We are currently already partnered with several Dutch hospitals and a small number of internationally renowned institutions.
Focus in this feasibility phase will be put on in-depth market study with/on end-users (key stakeholders) and the legal framework surrounding the innovation and future implementation within European hospitals. Also market sizes will be calculated further, a roadmap to regulatory approval set up, purchase (department) procedures per country worked out, and pricing strategy set after clear cost and value assessment. Various international partnerships will be assessed to accelerate the project and enhance its impact via well-established companies in the medical imaging technology workflow (Siemens, SECTRA, Phillips, Envoy.ai, et cetera).
An important part of the study will address orthopedic device manufacturers. We will assess the possibility to extent our business model to create a second-side to the marketplace; As orthopedic device makers spend approximately 36% on marketing and sales (almost 11B USD in 2017 for the top ten manufacturers)
Focus in this feasibility phase will be put on in-depth market study with/on end-users (key stakeholders) and the legal framework surrounding the innovation and future implementation within European hospitals. Also market sizes will be calculated further, a roadmap to regulatory approval set up, purchase (department) procedures per country worked out, and pricing strategy set after clear cost and value assessment. Various international partnerships will be assessed to accelerate the project and enhance its impact via well-established companies in the medical imaging technology workflow (Siemens, SECTRA, Phillips, Envoy.ai, et cetera).
An important part of the study will address orthopedic device manufacturers. We will assess the possibility to extent our business model to create a second-side to the marketplace; As orthopedic device makers spend approximately 36% on marketing and sales (almost 11B USD in 2017 for the top ten manufacturers)
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/837120 |
| Start date: | 01-12-2018 |
| End date: | 31-05-2019 |
| Total budget - Public funding: | 71 429,00 Euro - 50 000,00 Euro |
Cordis data
Original description
Healthplus.ai has developed a Proof-of-Concept version (TRL level 3) of an Artificial Intelligence (AI) tool to be offered as a Software as a Service (SaaS) solution and able to automatically and very precisely annotate, segment and 3D visualize unique bone and fracture patient cases (goal is >98% accuracy compared to 90-92 with current solutions), within minutes (instead of hours to days), and at a fraction of current cost (€10 vs €1,200). This process will hence also enable automated and expedient determination to do exact measurements of distances, angles, depths, and making a list of required prosthetic materials to perform the bone operation as efficient and effective as possible. We are currently already partnered with several Dutch hospitals and a small number of internationally renowned institutions.Focus in this feasibility phase will be put on in-depth market study with/on end-users (key stakeholders) and the legal framework surrounding the innovation and future implementation within European hospitals. Also market sizes will be calculated further, a roadmap to regulatory approval set up, purchase (department) procedures per country worked out, and pricing strategy set after clear cost and value assessment. Various international partnerships will be assessed to accelerate the project and enhance its impact via well-established companies in the medical imaging technology workflow (Siemens, SECTRA, Phillips, Envoy.ai, et cetera).
An important part of the study will address orthopedic device manufacturers. We will assess the possibility to extent our business model to create a second-side to the marketplace; As orthopedic device makers spend approximately 36% on marketing and sales (almost 11B USD in 2017 for the top ten manufacturers)
Status
CLOSEDCall topic
EIC-SMEInst-2018-2020Update Date
27-10-2022
Images
No images available.
Geographical location(s)
Search
